Ubs Group Ag Opgen Inc Transaction History

Ubs Group Ag

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$0.12 - $62.0 $6,441 - $3.33 Million	-53,676 Reduced 78.89%	14,361 $2,000
Q3 2022 Nov 10, 2022	BUY	$0.39 - $78.8 $25,261 - $5.1 Million	64,773 Added 1984.47%	68,037 $20,000
Q2 2022 Aug 10, 2022	SELL	$0.32 - $0.79 $3,805 - $9,394	-11,892 Reduced 78.46%	3,264 $2,000
Q1 2022 May 16, 2022	BUY	$0.72 - $1.11 $10,722 - $16,530	14,892 Added 5640.91%	15,156 $11,000
Q4 2021 Feb 14, 2022	SELL	$1.0 - $2.94 $5,463 - $16,061	-5,463 Reduced 95.39%	264 $0
Q3 2021 Nov 15, 2021	BUY	$2.18 - $3.58 $11,909 - $19,557	5,463 Added 2069.32%	5,727 $17,000
Q1 2021 May 12, 2021	SELL	$1.8 - $3.55 $2,795 - $5,513	-1,553 Reduced 85.47%	264 $1,000
Q4 2020 Feb 11, 2021	SELL	$1.7 - $2.47 $74 - $108	-44 Reduced 2.36%	1,817 $4,000
Q3 2020 Nov 12, 2020	SELL	$1.98 - $3.37 $37,204 - $63,322	-18,790 Reduced 90.99%	1,861 $4,000
Q2 2020 Jul 31, 2020	BUY	$1.88 - $2.59 $19,369 - $26,684	10,303 Added 99.57%	20,651 $42,000
Q1 2020 May 01, 2020	BUY	$1.14 - $4.04 $11,796 - $41,805	10,348 New	10,348 $26,000
Q4 2019 Feb 14, 2020	SELL	$1.02 - $7.18 $882 - $6,210	-865 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.9 - $8.02 $4,238 - $6,937	865 New	865 $6,000

Ticker OPGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,698,500
Market Cap $38.7M
Description
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.